Literature DB >> 1908158

Biological properties of RB51; a stable rough strain of Brucella abortus.

G G Schurig1, R M Roop, T Bagchi, S Boyle, D Buhrman, N Sriranganathan.   

Abstract

A rifampin-resistant mutant of Brucella abortus, designated RB51, was derived by repeated passage of strain 2308 on Trypticase soy supplemented with 1.5% agar and varying concentrations rifampin or penicillin. The RB51 colonies absorbed crystal violet and RB51 cell suspensions autoagglutinated, indicating a rough type colonial morphology for this strain. No O-chain component was detected in lipopolysaccharide (LPS) extracted from RB51 on SDS-PAGE gels stained with silver. Western blot analysis with the monoclonal antibody BRU 38, which is specific for the perosamine homopolymer O-chain of smooth Brucella LPS, indicated that the LPS of RB51 is highly deficient in O-chain when compared with the parenteral smooth strain 2308 or rough strain 45/20. Biochemically, RB51 resembles parental strain 2308 in its ability to utilize erythritol. Intraperitoneal inoculation of RB51 into mice results in a splenic colonization which is cleared within four weeks post infection. RB51 does not revert to smooth colony morphology upon passage in vivo (mice) or in vitro. Mice infected with RB51 produce antibodies against B. abortus antigens including class 2 and 3 outer membrane proteins but not against the O-chain. Furthermore, rabbits, goats and cattle hyperimmunized with sonicates of RB51 develop antibodies to B. abortus cellular antigens but do not develop antibodies specific for the O-chain. Immunization of mice with 1 x 10(8) viable RB51 organisms confers significant protection against challenge with virulent B. abortus strain 2308.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1908158     DOI: 10.1016/0378-1135(91)90091-s

Source DB:  PubMed          Journal:  Vet Microbiol        ISSN: 0378-1135            Impact factor:   3.293


  130 in total

1.  Effect of vaccination with Brucella abortus strain RB51 on heifers and pregnant cattle.

Authors:  F A Uza; L Samartino; G Schurig; A Carrasco; K Nielsen; R F Cabrera; H R Taddeo
Journal:  Vet Res Commun       Date:  2000-04       Impact factor: 2.459

2.  Regulation of the mitogen-activated protein kinases by Brucella spp. expressing a smooth and rough phenotype: relationship to pathogen invasiveness.

Authors:  María P Jiménez de Bagüés; Antoine Gross; Annie Terraza; Jacques Dornand
Journal:  Infect Immun       Date:  2005-05       Impact factor: 3.441

3.  Evaluation of protection afforded by Brucella abortus and Brucella melitensis unmarked deletion mutants exhibiting different rates of clearance in BALB/c mice.

Authors:  M M Kahl-McDonagh; T A Ficht
Journal:  Infect Immun       Date:  2006-07       Impact factor: 3.441

Review 4.  Current status of veterinary vaccines.

Authors:  Els N T Meeusen; John Walker; Andrew Peters; Paul-Pierre Pastoret; Gregers Jungersen
Journal:  Clin Microbiol Rev       Date:  2007-07       Impact factor: 26.132

5.  Immune and pathologic responses in mice infected with Brucella abortus 19, RB51, or 2308.

Authors:  M G Stevens; S C Olsen; G W Pugh; M V Palmer
Journal:  Infect Immun       Date:  1994-08       Impact factor: 3.441

6.  Carboxyl-terminal protease regulates Brucella suis morphology in culture and persistence in macrophages and mice.

Authors:  Aloka B Bandara; Nammalwar Sriranganathan; Gerhardt G Schurig; Stephen M Boyle
Journal:  J Bacteriol       Date:  2005-08       Impact factor: 3.490

7.  Comparison of immune responses and resistance to brucellosis in mice vaccinated with Brucella abortus 19 or RB51.

Authors:  M G Stevens; S C Olsen; G W Pugh; D Brees
Journal:  Infect Immun       Date:  1995-01       Impact factor: 3.441

8.  Cloning and sequencing of yajC and secD homologs of Brucella abortus and demonstration of immune responses to YajC in mice vaccinated with B. abortus RB51.

Authors:  R Vemulapalli; A J Duncan; S M Boyle; N Sriranganathan; T E Toth; G G Schurig
Journal:  Infect Immun       Date:  1998-12       Impact factor: 3.441

9.  Lymphocyte proliferation in response to Brucella abortus RB51 and 2308 proteins in RB51-vaccinated or 2308-infected cattle.

Authors:  M G Stevens; S C Olsen; N F Cheville
Journal:  Infect Immun       Date:  1996-03       Impact factor: 3.441

10.  Antibody responses to Brucella abortus 2308 in cattle vaccinated with B. abortus RB51.

Authors:  M G Stevens; S C Olsen
Journal:  Infect Immun       Date:  1996-03       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.